GO:0030070 insulin processing: Proteolytic Maturation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030070 insulin processing describes the proteolytic conversion of preproinsulin to mature insulin, including signal peptide removal and excision of the C peptide.
• The process occurs in the secretory pathway and is catalyzed by prohormone convertases and carboxypeptidase E within immature secretory granules.
• Mature insulin consists of A and B chains linked by disulfide bridges, while the C peptide is released in equimolar amounts.
• Defects in insulin processing are linked to diabetes and impaired glucose homeostasis, and insulin fragments influence T cell recognition.
• Insulin processing intersects with insulin receptor trafficking and downstream signaling, including second messenger pathways.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of processing enzymes and their substrates.
Description
Insulin processing (GO:0030070) is the biological process by which the precursor preproinsulin is converted into mature, biologically active insulin through sequential proteolytic cleavages. This process is essential for the production of the hormone that regulates blood glucose, and its dysregulation is associated with diabetes and other metabolic disorders. Understanding insulin processing provides a foundation for studying secretory granule biogenesis, prohormone maturation, and endocrine cell biology. The process also generates the C peptide, which is co-secreted with insulin and has been used as a marker of beta-cell function. Research into insulin processing has been informed by studies on T cell recognition of insulin fragments, which highlighted the immunological relevance of processing intermediates. Additionally, insulin signaling and receptor trafficking are intertwined with the processing pathway, as the insulin receptor itself undergoes cellular trafficking and processing. Insulin second messengers further modulate downstream effects, linking processing to broader metabolic regulation.
insulin processing At A Glance
| GO ID | GO:0030070 |
|---|---|
| GO term | insulin processing |
| Ontology | biological_process |
| Synonym | none |
| Major function | Proteolytic maturation of preproinsulin to mature insulin |
| Cellular location | Secretory pathway, immature secretory granules |
| Key enzymes | Prohormone convertases (e.g., PCSK1, PCSK2), carboxypeptidase E (CPE) |
| Substrate | Preproinsulin |
| Products | Mature insulin (A and B chains), C peptide |
What Is GO:0030070?
According to the Gene Ontology, insulin processing (GO:0030070) is defined as the formation of mature insulin by proteolysis of the precursor preproinsulin. The signal sequence is first cleaved from preproinsulin to form proinsulin; proinsulin is then cleaved to release the C peptide, leaving the A and B chains of mature insulin linked by disulfide bridges.
Why Is insulin processing Important in Cell Biology?
Insulin processing is critical for the production of mature insulin, the central hormone regulating glucose homeostasis. Defects in this pathway can lead to impaired insulin secretion and diabetes. The process also serves as a model for understanding prohormone processing in endocrine cells and has implications for the development of insulin analogs and biosimilars. Furthermore, insulin processing intermediates can influence immune recognition, as demonstrated by T cell responses to insulin fragments.
• Essential for generating mature insulin, which controls blood glucose levels.
• Dysregulation is linked to diabetes mellitus and metabolic syndrome.
• Provides a paradigm for prohormone processing in secretory granules.
• C peptide, a byproduct, is a clinical marker of beta-cell function.
• Processing intermediates can be recognized by the immune system, with implications for autoimmunity.
• Insulin receptor trafficking and processing are interconnected with insulin action.
• Insulin second messengers mediate diverse cellular effects.
• Biosimilar insulins rely on understanding processing for production and quality control.
• Dietary factors, such as oat processing, can influence postprandial insulin responses.
• Insulin regulates microRNA secretion into extracellular vesicles, linking processing to intercellular communication.
What Happens During insulin processing?
Signal peptide cleavage
In simple terms: The first step removes a short leader sequence from the precursor protein.
Preproinsulin contains an N-terminal signal peptide that directs the nascent polypeptide to the endoplasmic reticulum. The signal peptide is cleaved by signal peptidase, yielding proinsulin. This step is a prerequisite for subsequent folding and transport to the Golgi apparatus.
Folding and disulfide bond formation
In simple terms: The protein folds into its proper shape and forms chemical links called disulfide bonds.
Proinsulin folds in the endoplasmic reticulum, forming three disulfide bonds that connect the A and B chains and the C peptide. Correct folding is essential for exit from the ER and transport to the Golgi.
Packaging into secretory granules
In simple terms: The precursor is packed into small vesicles for further processing.
Proinsulin is transported to the trans-Golgi network and packaged into immature secretory granules. These granules undergo acidification and maturation, creating the environment for proteolytic processing.
Proteolytic cleavage by prohormone convertases
In simple terms: Enzymes cut the precursor at specific sites to release the mature hormone.
Within immature secretory granules, prohormone convertases (PC1/3 and PC2, encoded by PCSK1 and PCSK2) cleave proinsulin at two sites: the B-chain/C-peptide junction and the C-peptide/A-chain junction. This generates intermediates that are further trimmed by carboxypeptidase E (CPE) to remove basic amino acid residues.
Formation of mature insulin and C peptide
In simple terms: The final product is the active hormone plus a leftover piece.
The end result of processing is mature insulin, consisting of the A and B chains linked by disulfide bridges, and the C peptide, which is released in equimolar amounts. Both are stored in mature secretory granules and co-secreted upon stimulation.
Key Genes Involved in GO:0030070 insulin processing
The following genes and proteins are central to insulin processing, including the substrate preproinsulin and the enzymes that catalyze its maturation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| INS | Encodes preproinsulin, the precursor of insulin | Mutations cause diabetes; target for knockout and knock-in studies |
| PCSK1 | Prohormone convertase 1/3, cleaves proinsulin | Defects cause obesity and diabetes; knockout models available |
| PCSK2 | Prohormone convertase 2, cleaves proinsulin | Essential for processing in beta cells; knockout models |
| CPE | Carboxypeptidase E, trims basic residues | Mutations linked to diabetes; knockout models |
| SLC30A8 | Zinc transporter, involved in insulin granule maturation | Risk gene for type 2 diabetes |
| CHGA | Chromogranin A, component of secretory granules | Marker of neuroendocrine cells |
| PAM | Peptidylglycine alpha-amidating monooxygenase | May modify processing intermediates |
| SEC11A | Signal peptidase complex subunit | Involved in signal peptide cleavage |
| SRP9 | Signal recognition particle subunit | Targets preproinsulin to ER |
| HSPA5 | ER chaperone BiP | Facilitates proinsulin folding |
| PDIA3 | Protein disulfide isomerase | Catalyzes disulfide bond formation |
| ERO1A | ER oxidoreductin 1 | Supports oxidative folding |
| COPA | Coatomer subunit, ER-to-Golgi transport | Affects proinsulin trafficking |
| ARF1 | Small GTPase, vesicle formation | Regulates secretory granule biogenesis |
| RAB3A | Regulates secretory vesicle exocytosis | Involved in insulin secretion |
| SNAP25 | SNARE protein, vesicle fusion | Required for insulin release |
| VAMP2 | SNARE protein, vesicle fusion | Required for insulin release |
| STX1A | Syntaxin 1A, SNARE protein | Required for insulin release |
How Is insulin processing Regulated?
Insulin processing is regulated at multiple levels. The expression of prohormone convertases and carboxypeptidase E is controlled by developmental and metabolic signals. Glucose stimulates insulin biosynthesis and processing, while prolonged hyperglycemia can impair processing. Additionally, the acidic environment of secretory granules is maintained by V-ATPase, which is necessary for optimal enzyme activity. Insulin signaling itself can feedback on processing through second messengers. The process is also influenced by the trafficking of the insulin receptor, which undergoes its own processing and trafficking.
insulin processing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| INS | Neonatal diabetes, type 1 diabetes | Knockout or point mutation in beta cell lines |
| PCSK1 | Obesity, diabetes | Knockout mouse or CRISPR knockout in cell lines |
| PCSK2 | Type 2 diabetes | Knockout models in beta cells |
| CPE | Diabetes, obesity | Knockout or point mutation models |
| SLC30A8 | Type 2 diabetes risk | Knock-in of risk variants |
Diabetes mellitus
Defects in insulin processing enzymes, such as PCSK1, PCSK2, and CPE, lead to impaired production of mature insulin and are associated with diabetes. Mutations in INS cause neonatal diabetes and monogenic diabetes. The processing pathway is a target for therapeutic intervention and biomarker development.
Autoimmune diabetes
Insulin fragments generated during processing can be recognized by T cells, contributing to autoimmune responses in type 1 diabetes. The study of processing intermediates has provided insights into the immunogenicity of insulin.
Metabolic syndrome and obesity
Dysregulation of prohormone convertases is linked to obesity and impaired glucose tolerance. PCSK1 mutations cause severe obesity and endocrine dysfunction.
Insulin receptor trafficking disorders
Abnormal processing of the insulin receptor can lead to insulin resistance. The receptor undergoes cellular trafficking and processing that are essential for signal transduction.
From insulin processing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PCSK1 affect insulin processing? | PCSK1 knockout cell line (e.g., INS-1, MIN6) |
| Does a specific point mutation in INS cause misfolding? | Point mutation knock-in in beta cells |
| Can a tagged proinsulin track processing? | Knock-in of fluorescent tag (e.g., GFP) at INS locus |
| Does overexpression of CPE enhance processing? | Overexpression of CPE in beta cell lines |
| What is the role of SLC30A8 in granule maturation? | Knockout or knock-in of SLC30A8 |
| Can CRISPR library screening identify new processing regulators? | Genome-wide CRISPR knockout library in beta cells |
How to Study the insulin processing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry | Molecular masses of insulin and intermediates | Characterization of processing products |
| ELISA | Insulin and C peptide concentrations | Quantification of processing efficiency |
| Western blot | Protein levels of proinsulin and enzymes | Assessment of processing enzyme expression |
| Fluorescence microscopy | Localization of tagged proteins | Tracking of granule maturation |
| CRISPR knockout screening | Gene essentiality for processing | Discovery of novel regulators |
| RNA-seq | Transcript levels of processing genes | Expression profiling in disease models |
| Co-immunoprecipitation | Protein-protein interactions | Identification of processing complexes |
Proteomics and mass spectrometry
Mass spectrometry can identify and quantify insulin processing intermediates and mature products, providing direct evidence of proteolytic cleavage.
Immunoassays
ELISA and radioimmunoassay can measure insulin and C peptide levels, distinguishing mature insulin from precursors.
Fluorescence imaging
Tagged proinsulin or processing enzymes can be visualized in live cells to track trafficking and granule maturation.
CRISPR screening
Genome-wide knockout screens can identify genes required for insulin processing and secretion, using readouts such as insulin ELISA or fluorescent reporters.
How CRISPR Can Be Used to Study GO:0030070 insulin processing
Knockout
CRISPR knockout of processing enzymes (e.g., PCSK1, PCSK2, CPE) in beta cell lines abolishes or reduces mature insulin production, allowing functional assessment of each enzyme's contribution.
Point Mutation
Introducing disease-associated point mutations (e.g., in INS) via CRISPR base editing or homology-directed repair can model misfolding and impaired processing, linking genotype to phenotype.
Knock-in
Knock-in of tags (e.g., GFP, HA) at the INS locus enables real-time tracking of proinsulin trafficking and processing in live cells.
Overexpression
Overexpression of processing enzymes or substrate can enhance or saturate the pathway, revealing rate-limiting steps and regulatory mechanisms.
How EDITGENE Supports insulin processing Research
Researchers studying insulin processing-related genes often need to determine whether a candidate gene is causally involved in the maturation of insulin or merely correlated with changes in beta-cell function. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies, from gene knockout to precise point mutations and knock-in reporters.
Contact EDITGENE today to design your custom CRISPR model for insulin processing research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| P4HB Knockout HEK293 Cell Line | EDJ-KQ3165 | Human | 5034 | Details Get a Quote |
| PCSK1 Knockout HEK293 Cell Line | EDJ-KQ4651 | Human | 5122 | Details Get a Quote |
| PCSK2 Knockout HEK293 Cell Line | EDJ-KQ5421 | Human | 5126 | Details Get a Quote |
| YIPF5 Knockout HEK293 Cell Line | EDJ-KQ9711 | Human | 81555 | Details Get a Quote |
| SLC30A8 Knockout HEK293 Cell Line | EDJ-KQ11217 | Human | 169026 | Details Get a Quote |
| ERO1B Knockout HEK293 Cell Line | EDJ-KQ13323 | Human | 56605 | Details Get a Quote |
| SLC30A5 Knockout HEK293 Cell Line | EDJ-KQ15323 | Human | 64924 | Details Get a Quote |
| P4HB Knockout A-549 Cell Line | EDJ-KQ25934 | Human | 5034 | Details Get a Quote |
| P4HB Knockout HCT 116 Cell Line | EDJ-KQ25936 | Human | 5034 | Details Get a Quote |
| P4HB Knockout HeLa Cell Line | EDJ-KQ25937 | Human | 5034 | Details Get a Quote |
| SLC30A5 Knockout A-549 Cell Line | EDJ-KQ46032 | Human | 64924 | Details Get a Quote |
| SLC30A5 Knockout HCT 116 Cell Line | EDJ-KQ46033 | Human | 64924 | Details Get a Quote |
| SLC30A5 Knockout HeLa Cell Line | EDJ-KQ46034 | Human | 64924 | Details Get a Quote |
| PCSK1 Knockout HeLa Cell Line | EDJ-KQ28583 | Human | 5122 | Details Get a Quote |
| YIPF5 Knockout A-549 Cell Line | EDJ-KQ36501 | Human | 81555 | Details Get a Quote |
Displaying Records 1 To 15 Of 28 Records
Frequently Asked Questions About insulin processing
What is insulin processing?
Insulin processing (GO:0030070) is the proteolytic conversion of preproinsulin to mature insulin, involving removal of the signal peptide and C peptide.
What genes are involved in insulin processing?
Key genes include INS, PCSK1, PCSK2, CPE, and SLC30A8, among others.
Where does insulin processing occur?
It occurs in the secretory pathway of pancreatic beta cells, primarily in immature secretory granules.
What enzymes cleave proinsulin?
Prohormone convertases PC1/3 and PC2, encoded by PCSK1 and PCSK2, cleave proinsulin, followed by carboxypeptidase E.
What is the role of the C peptide in insulin processing?
The C peptide is released during processing and is co-secreted with insulin; it serves as a marker of beta-cell function.
How is insulin processing studied?
Methods include mass spectrometry, ELISA, Western blot, fluorescence imaging, and CRISPR screening.
What diseases are linked to defects in insulin processing?
Diabetes mellitus, obesity, and metabolic syndrome are associated with impaired processing.
Can CRISPR be used to study insulin processing?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal studies of processing genes.
What is the difference between proinsulin and mature insulin?
Proinsulin is the precursor that includes the C peptide; mature insulin consists of A and B chains after C peptide removal.
How does insulin processing relate to insulin signaling?
Processing produces mature insulin that binds the insulin receptor; receptor trafficking and second messengers are interconnected with processing.
Conclusion
Insulin processing (GO:0030070) is a fundamental biological process that converts preproinsulin to mature insulin through sequential proteolytic cleavages. Its tight regulation is essential for glucose homeostasis, and its dysregulation contributes to diabetes and related metabolic disorders. Understanding the molecular players and mechanisms provides opportunities for therapeutic intervention and biomarker development. CRISPR-based models offer powerful tools to dissect the causal roles of processing genes and to identify novel regulators, accelerating research in this field.
References
- 1. Gradehandt G et al.. 1988. Processing requirements for the recognition of insulin fragments by murine T cells.. Immunol Rev 106:59-75 PMID: 2473028
- 2. Hutton JC. 1994. Insulin secretory granule biogenesis and the proinsulin-processing endopeptidases.. Diabetologia 37 Suppl 2:S48-56 PMID: 7821740
- 3. Musa-Veloso K et al.. 2021. A Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Effects of Oats and Oat Processing on Postprandial Blood Glucose and Insulin Responses.. J Nutr 151(2):341-351 PMID: 33296453
- 4. Strålfors P. 1997. Insulin second messengers.. Bioessays 19(4):327-35 PMID: 9136630
- 5. Knutson VP. 1991. Cellular trafficking and processing of the insulin receptor.. FASEB J 5(8):2130-8 PMID: 2022311
- 7. Heinemann L. 2012. Biosimilar insulins.. Expert Opin Biol Ther 12(8):1009-16 PMID: 22583127
- 8. Lino M et al.. 2024. Multi-step regulation of microRNA expression and secretion into small extracellular vesicles by insulin.. Cell Rep 43(7):114491 PMID: 39002127
